Profile
ACIU VRTX REGN VRNA ARGX ALNY
Company Name AC Immune S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $280.67M $116.06B $76.56B $72.68B $53.66B $52.51B
Employees 0.13K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Andrea Pfeifer Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ACIU VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ACIU VRTX REGN VRNA ARGX ALNY
Last Close $3.1 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $3.99 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.48 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -22.31 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 109.46 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ACIU VRTX REGN VRNA ARGX ALNY
1 Month Return 6.9 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 44.19 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 81.29 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 17.42 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 14.81 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -5.2 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -42.88 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
ACIU VRTX REGN VRNA ARGX ALNY
Asset Growth 26.31 % 14.15 % 53.91 %
Gross Profit Growth 11.42 % 12.5 % -
Revenue Growth 84.51 % 8.27 % -
Revenue 3 Year - -13.44 % -15.89 %
Revenue 5 Year -82.58 % 119.18 % -
Revenue 10 Year -49.87 % 429.43 % -
EBIT Growth 6.04 % 13.17 % -131.37 %
Net Income Growth 6.12 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share 47.56 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share -179.35 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share -363.33 % 1232.49 % -35.51 %
Operating Income Growth 2.32 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) 209 % -3.78 % -143.33 %
Operating 3 Year CFG 175.36 % -38.85 % -170.73 %
Operating 5 Year CFG -15.56 % 84.11 % 54.81 %
Operating 10 Year CFG 307.6 % 517.51 % 40.15 %
EPS Growth 20.31 % 10.39 % -214.81 %
EPS Diluted Growth 20.31 % 10.27 % -208.93 %
Book Value Per Share -40.63 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -63.61 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share -70.82 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share 165.84 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 55.19 % 0.06 % 139.05 %
Free Cash Flow Growth 206.63 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ACIU VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -26.55 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -49.04 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -54.91 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.01 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.8 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -173.27 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -866.5 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 13.57 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 5.31 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 389.94 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 15.2 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.42 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.43 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 126.34 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -147.39 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.33 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -866.5 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -5.14 34.78 18.43 -995.27 126.92 237.2
Price To Operating Cash Flows Ratio TTM -5.26 31.09 15.15 -126.33 144.96 196.51
Price Cash Flow Ratio TTM -5.26 31.09 15.15 -126.33 144.96 196.51
Income Statement (TTM)
ACIU VRTX REGN VRNA ARGX ALNY
Revenue $0.03B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $-0.04B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio -129.12% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.05B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.05B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -0.51 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ACIU VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.12B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0.11B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0.13B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.23B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ACIU VRTX REGN VRNA ARGX ALNY
Net Income $-0.05B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 29.61
AARD Aardvark Therapeutics, Inc. Common Stock 14.34
ABCL AbCellera Biologics Inc. 3.54
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.09
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.08
ABPWW 0.02
ABSI Absci Corporation 3.4465
ABUS Arbutus Biopharma Corporation 4.9611
ABVC ABVC BioPharma, Inc. 2.03
ABVX Abivax SA American Depositary Shares 110.73
ACAD ACADIA Pharmaceuticals Inc. 27.32
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4905
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.445
ACLX Arcellx, Inc. 67.6275
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01623 168.34
GWX SPDR S&P International Small Cap ETF 0.02 40.99
BIB ProShares Ultra Nasdaq Biotechnology 0.0179287 79.6189
SBIO ALPS Medical Breakthroughs ETF 0.002 50.715
BMED BlackRock Future Health ETF 0.0106 30.21
IBBQ Invesco Nasdaq Biotechnology ETF 0.026203 28.45
DFAT Dimensional U.S. Targeted Value ETF 0.0001165 60.695
DFAS Dimensional U.S. Small Cap ETF 0.00073588 71
DFAC Dimensional U.S. Core Equity 2 ETF 0.00006194 39.5858
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0251 7.051
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0251 8.255
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0256 50.27
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.0251 8.278
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0256 59.28
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 34.8557
DFSU Dimensional US Sustainability Core 1 ETF 0.00048512 43.48
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0251 6.2025
DXUV Dimensional ETF Trust 0.00339849 59.9661
Unlock